当前位置: X-MOL 学术Leuk. Suppl. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Chronic lymphocytic leukemia: treatment of relapse
Leukemia Supplements Pub Date : 2012-08-09 , DOI: 10.1038/leusup.2012.18
M Montillo 1
Affiliation  

Despite significant advances in the frontline treatment of chronic lymphocytic leukemia (CLL), patients eventually experience disease progression. Treatment selection of relapsed disease depends upon a variety of factors, including patient age, performance status, duration of response to initial therapy, type of prior therapy, disease-related manifestations and genetic abnormalities within the CLL cells. This presentation offers synthetic overview of the options in this field.



中文翻译:

慢性淋巴细胞白血病:复发的治疗

尽管慢性淋巴细胞白血病 (CLL) 的一线治疗取得了重大进展,但患者最终会经历疾病进展。复发疾病的治疗选择取决于多种因素,包括患者年龄、体能状态、对初始治疗的反应持续时间、先前治疗的类型、疾病相关表现和 CLL 细胞内的遗传异常。本演示文稿提供了该领域选项的综合概述。

更新日期:2012-08-09
down
wechat
bug